Literature DB >> 33316777

Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.

Ruyue Tian1,2, Jiexuan Hu1, Xiao Ma1, Lei Liang2, Shuilong Guo3.   

Abstract

PURPOSE: Gastric cancer (GC) is one of the most common and fatal malignancies globally. While microsatellite instability (MSI) index has earlier been correlated with survival outcome in gastric cancer patients, the present study aims to construct a risk-stratification model based on immune-related genes in GC patients with varying MSI status.
RESULTS: The univariate and multivariate Cox regression analyses identified SEMA7A, NUDT6, SCGB3A1, NPR3, PTH1R, and SHC4 as signature genes, which were used to build the prognostic model for GC patients with microsatellite instability-low (MSI-L) and microsatellite stable (MSS). Whereas, for GC patients with microsatellite instability-high (MSI-H), prognostic model was established with three genes (SEMA6A, LTBP1, and BACH2), based on the univariate and multivariate Cox regression, and Kaplan-Meier survival analyses.
CONCLUSION: The prognostic immune-related gene signature identified in this study may offer new targets for personalized treatment and immunotherapy for GC patients with MSI-H or MSI-L/MSS status.
METHODS: The Cancer Genome Atlas (TCGA) and ImmPort databases were used to extract expression data and to explore prognostic genes from the immune-related genes (IRGs), respectively. Univariate and multivariate Cox regression analysis were applied to identify IRGs correlated with patient prognosis. The regulatory network between prognostic IRGs and TFs were performed using R software.

Entities:  

Keywords:  The Cancer Genome Atlas; gastric cancer; immune-related genes; microsatellite instability; survival analysis

Mesh:

Substances:

Year:  2020        PMID: 33316777      PMCID: PMC7880323          DOI: 10.18632/aging.202271

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  29 in total

1.  Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery.

Authors:  Wen-Liang Fang; Shih-Ching Chang; Yuan-Tzu Lan; Kuo-Hung Huang; Jen-Hao Chen; Su-Shun Lo; Mao-Chih Hsieh; Anna Fen-Yau Li; Chew-Wun Wu; Shih-Hwa Chiou
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

2.  Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.

Authors:  Razvan Cristescu; Jeeyun Lee; Michael Nebozhyn; Kyoung-Mee Kim; Jason C Ting; Swee Seong Wong; Jiangang Liu; Yong Gang Yue; Jian Wang; Kun Yu; Xiang S Ye; In-Gu Do; Shawn Liu; Lara Gong; Jake Fu; Jason Gang Jin; Min Gew Choi; Tae Sung Sohn; Joon Ho Lee; Jae Moon Bae; Seung Tae Kim; Se Hoon Park; Insuk Sohn; Sin-Ho Jung; Patrick Tan; Ronghua Chen; James Hardwick; Won Ki Kang; Mark Ayers; Dai Hongyue; Christoph Reinhard; Andrey Loboda; Sung Kim; Amit Aggarwal
Journal:  Nat Med       Date:  2015-04-20       Impact factor: 53.440

3.  Type 1 receptor parathyroid hormone (PTH1R) influences breast cancer cell proliferation and apoptosis induced by high levels of glucose.

Authors:  Huasheng Liang; Yuhua Zhong; Yu Huang; Genben Chen
Journal:  Med Oncol       Date:  2011-02-11       Impact factor: 3.064

4.  Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.

Authors:  Bo Hwa Sohn; Jun-Eul Hwang; Hee-Jin Jang; Hyun-Sung Lee; Sang Cheul Oh; Jae-Jun Shim; Keun-Wook Lee; Eui Hyun Kim; Sun Young Yim; Sang Ho Lee; Jae-Ho Cheong; Woojin Jeong; Jae Yong Cho; Joohee Kim; Jungsoo Chae; Jeeyun Lee; Won Ki Kang; Sung Kim; Sung Hoon Noh; Jaffer A Ajani; Ju-Seog Lee
Journal:  Clin Cancer Res       Date:  2017-07-26       Impact factor: 12.531

5.  Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1.

Authors:  Toru Aoyama; Takaki Yoshikawa; Takafumi Watanabe; Tsutomu Hayashi; Takashi Ogata; Haruhiko Cho; Akira Tsuburaya
Journal:  Gastric Cancer       Date:  2011-02-16       Impact factor: 7.370

6.  The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.

Authors:  Soo Young Kim; Yoon Young Choi; Ji Yeong An; Hyun Beak Shin; Ara Jo; Hyeji Choi; Sang Hyuk Seo; Hui-Jae Bang; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh
Journal:  Int J Cancer       Date:  2015-02-26       Impact factor: 7.396

7.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

8.  Association between BACH2 expression and clinical prognosis in diffuse large B-cell lymphoma.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Hiroki Katsushima; Taro Takahashi; Joji Yamamoto; Hisayuki Yokoyama; Osamu Sasaki; Osamu Fukuhara; Jun Nomura; Kenichi Ishizawa; Ryo Ichinohasama; Akihiko Muto; Kazuhiko Igarashi; Hideo Harigae
Journal:  Cancer Sci       Date:  2014-03-08       Impact factor: 6.716

9.  MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression.

Authors:  Xin Chen; Bo Yue; Changming Zhang; Meihao Qi; Jianhua Qiu; Ye Wang; Jun Chen
Journal:  Biosci Rep       Date:  2017-06-08       Impact factor: 3.840

Review 10.  Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches.

Authors:  Margherita Ratti; Andrea Lampis; Jens C Hahne; Rodolfo Passalacqua; Nicola Valeri
Journal:  Cell Mol Life Sci       Date:  2018-09-01       Impact factor: 9.261

View more
  5 in total

1.  Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients.

Authors:  Taohua Yue; Shuai Zuo; Jing Zhu; Shihao Guo; Zhihao Huang; Jichang Li; Xin Wang; Yucun Liu; Shanwen Chen; Pengyuan Wang
Journal:  Front Cell Dev Biol       Date:  2021-08-03

2.  Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.

Authors:  Feng Qiu; Yumei Zhu; Yafeng Shi; Jingjing Ji; Yingchao Jin
Journal:  Dis Markers       Date:  2021-11-11       Impact factor: 3.434

3.  Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma.

Authors:  Bin Wang; Lixiao Liu; Jinting Wu; Xiaolu Mao; Zhen Fang; Yingyu Chen; Wenfeng Li
Journal:  Front Genet       Date:  2022-02-09       Impact factor: 4.599

4.  Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer.

Authors:  Rui Luo; Yang Li; Zhijie Wu; Yuanxin Zhang; Jian Luo; Keli Yang; Xiusen Qin; Huaiming Wang; Rongkang Huang; Hui Wang; Hongzhi Luo
Journal:  Front Surg       Date:  2022-03-31

5.  Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.

Authors:  Weijun Ma; Weidong Li; Lei Xu; Lu Liu; Yu Xia; Liping Yang; Mingxu Da
Journal:  Pathol Oncol Res       Date:  2021-09-10       Impact factor: 3.201

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.